Dexrazoxane is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Gland Pharma Limited. The primary component is Dexrazoxane Hydrochloride.
Product ID | 68083-195_9a0e54ca-a444-4474-94fc-0b4ac5b0e394 |
NDC | 68083-195 |
Product Type | Human Prescription Drug |
Proprietary Name | Dexrazoxane |
Generic Name | Dexrazoxane For Injection |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2016-12-05 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA207321 |
Labeler Name | Gland Pharma Limited |
Substance Name | DEXRAZOXANE HYDROCHLORIDE |
Active Ingredient Strength | 500 mg/50mL |
Pharm Classes | Cytoprotective Agent [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2016-12-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA207321 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-12-05 |
Ingredient | Strength |
---|---|
DEXRAZOXANE HYDROCHLORIDE | 500 mg/50mL |
SPL SET ID: | c9c625fc-8852-4ed4-bcf2-63f46a706782 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9247 | Dexrazoxane | Dexrazoxane |
0143-9248 | Dexrazoxane | Dexrazoxane |
47781-578 | Dexrazoxane | Dexrazoxane for Injection |
51991-942 | Dexrazoxane | Dexrazoxane Hydrochloride |
55150-434 | DEXRAZOXANE | DEXRAZOXANE |
55150-437 | DEXRAZOXANE | DEXRAZOXANE |
68083-195 | Dexrazoxane | Dexrazoxane for Injection |
72266-101 | Dexrazoxane | Dexrazoxane for Injection |
72266-235 | Dexrazoxane | Dexrazoxane for Injection |
72611-716 | Dexrazoxane | Dexrazoxane for Injection |
76310-002 | Cardioxane | dexrazoxane |
67457-207 | Dexrazoxane Hydrochloride | dexrazoxane |
67457-208 | Dexrazoxane Hydrochloride | dexrazoxane |
0013-8717 | Zinecard | dexrazoxane |
0013-8727 | Zinecard | dexrazoxane |